Cargando…
The Endothelial Landscape and Its Role in Von Hippel–Lindau Disease
Von Hippel–Lindau disease (VHL) is a rare hereditary disease characterized by the predisposal to develop different types of highly vascularized tumors. VHL patients carry a VHL mutation that causes partial lack of functional VHL protein (pVHL) in all cells, and a total lack thereof in cells harborin...
Autores principales: | de Rojas-P, Isabel, Albiñana, Virginia, Taranets, Lyudmyla, Recio-Poveda, Lucía, Cuesta, Angel M., Popov, Nikita, Kronenberger, Thales, Botella, Luisa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465092/ https://www.ncbi.nlm.nih.gov/pubmed/34571962 http://dx.doi.org/10.3390/cells10092313 |
Ejemplares similares
-
Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease
por: Albiñana, Virginia, et al.
Publicado: (2017) -
Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial
por: González-Rodríguez, Beatriz, et al.
Publicado: (2019) -
Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel–Lindau Disease
por: Albiñana, Virginia, et al.
Publicado: (2020) -
The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease
por: Cuesta, A. M., et al.
Publicado: (2019) -
Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients
por: Albiñana, Virginia, et al.
Publicado: (2015)